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SPECIAL ARTICLE
Insights into neutralization of animal viruses gained from
study of influenza virus
INTRODUCTION
It has long been known that the binding of antibodies to viruses can result in
a loss of infectivity, or neutralization, but little is understood of the mechanism
or mechanisms of this process. This is probably because neutralization is a multi-
factorial phenomenon depending upon the nature of the virus itself, the particular
antigenic site involved, the isotype of immunoglobulin and the ratio of virus to
immunoglobulin (see below). Thus not only is it likely that neutralization of one
virus will differ from another but that changing the circumstances of neutralization
can change the mechanism itself. To give coherence to the topic we are
concentrating this review on one virus, influenza type A which is itself well studied
and reasonably well understood [1-3]. Reviews of the older literature can be found
in references 4 to 7.
INITIAL STAGES OF INFLUENZA VIRUS INFECTION
Any of the early stages of infection can in theory be the target of neutralization
of a virus and thus it is a prerequisite to the understanding of neutralization to
have a complete picture of these virus-cell interactions. An influenza virus particle
(Fig. 1) consists of a nucleocapsid structure surrounded by a lipid envelope derived
as the nucleocapsid buds through the plasma membrane. Both these structures
protect the viral genome from damage by nucleases. Embedded in the envelope
are haemagglutinin (HA) proteins (about 1000/particle [8]) which function as
ligands and attach the virus to specific cellular receptors. Fig. 2 shows five stages
of the early interactions of influenza virus with a susceptible target cell. The HA
binds to a carbohydrate moiety, N-acetyl neuraminic acid (NANA) (sialic acid).
This is almost certainly attached to a protein as NANA-bearing glycolipids are
short molecules, buried beneath the longer cell surface proteins and relatively
inaccessible to virus particles. Virus is then taken up into a vesicle by endocytosis.
A multi-stage process of 'uncoating' follows whereby the viral genome becomes
functional and able to direct virus multiplication. This commences when a proton
pump in the membrane acidifies the internal environment of the vesicle, causing
the HA to undergo a conformational change which leads to primary uncoating -
fusion of the viral and vesicle membranes and entry into the cytoplasm proper of
the nucleocapsid [10-12]. Details of secondary uncoating can only be surmised but
there have to be changes in nucleocapsid such as loss of proteins and/or relaxation
of structure so that the viral genome can be exposed sufficiently to be expressed.
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Fig. 1. Diagram (adapted from reference 56) of the structure of an influenza virus
particle (not to scale). The inner core structure contains eight RNA segments each
coated with nucleoprotein (NP) and containing one transcriptase complex composed
of PA, PB1 and PB2, and surrounded by a layer of Matrix (M) 1 protein. Around this
is a lipid membrane through which are inserted about 1000 haemagglutinin (HA)
trimers, 400 neuraminidase (NA) and around 20 matrix (M) 2 molecules.
(1)
(3)
Cytosol
(5)
Lysosome
Nucleus
Fig. 2. A schematic representation of the pathway of influenza virus entry into cells.
The stages at which neutralizing antibody may inhibit this process are discussed in the
text.
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The latter takes place in the cell nucleus and hence the nucleocapsid must be
transported to that location.
Other viruses enter cells with only minor variations upon the above theme.
Initially they all interact very specifically with a receptor on the cell surface which
is often, but not always, a protein. Viruses frequently utilise molecules which
perform some homeostatic function [9] and are therefore an obligatory feature of
the target cell. The reaction takes place between complementary sequences on the
virus (the attachment site) and the cell receptor unit. These are invariant
presumably since sequence changes would deny the recognition process upon
which infection ultimately depends. From there many enveloped and non-
enveloped viruses follow a pathway similar to influenza virus and enter the cell by
endocytosis. Other enveloped viruses (e.g. HIV [13], Newcastle Disease Virus [14])
enter cells by fusing with the plasma membrane itself at neutral pH.
MECHANISMS OF NEUTRALIZATION OF INFLUENZA VIRUS
Much of the following data come from our own laboratory. In the past we and
others have varied virus concentration according to the demands of different
technical procedures, often over many orders of magnitude which has made
comparisons uncertain. To avoid the problem we have more recently used a
constant virus concentration (500 units/ml) and varied only the antibody
concentration.
The role of aggregation in neutralization
Aggregation of influenza virus by antibody has been determined by counting
the aggregates and the number of particles contained therein under the EM. All
isotypes tested (IgG, A and M) caused aggregation and all gave a similar pattern
of aggregation [15,16]. Fig. 3 shows that as the IgG concentration increased,
aggregation increased and the infectivity of the virus fell. It was calculated that
at the point of maximum aggregation the potential loss of infectivity due to
aggregation alone was between 65 and 80%, but this did not fully account for
the 99% neutralization observed. With further increase in IgG concentration
aggregation decreased until the virus became as disperse as the non-neutralized
controls. There was no concomitant return of virus infectivity, demonstrating
that neutralization could not be due to aggregation alone, and that other
mechanisms must be operating.
Caution is needed in the interpretation of aggregation data as in some
virus-antibody mixtures the rise in aggregation preceded loss of infectivity. This
may have been caused by disruption of the aggregates, shifting the curve to the
right, or the process of drying the samples onto the EM grid may have enhanced
aggregation by concentrating the virus and shifted the curve to the left. Analysis
of the aggregates in solution (as with poliovirus: [17]) is needed to resolve the
practical implications of this issue.
Inhibition of attachment of virus to cells by neutralizing antibody
Neutralizing IgG mabs directed to sites A, B and D in the influenza HA [18] all
inhibited attachment and this correlated more closely with the loss of infectivity
than did aggregation. Reduction in attachment to tracheal epithelial (Fig. 4) and
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Fig. 3. Aggregation of FPV/R, a type A influenza virus (A/fowl plague virus/
Rostock/1/34: H7N1) by a mouse monoclonal IgG2a (HC2) directed against the HA.
The antibody concentration is expressed in haemagglutinin-inhibiting (HI) units
defined by that amount which will inhibit the agglutination of erythrocytes by four
HA units of virus. Virus (500 HA units/ml) and IgG were incubated together for 1 h
at 25 °C and the amount of aggregation determined by electron microscopy. This is
expressed as the average number of virions per aggregate (-A-) and compared to non-
neutralized controls ( ). Also shown is the extent of neutralization (-). From
reference 16.
BHK cells reached a maximum of approximately 60 and 40 % respectively but at
no point did this account fully for the > 999% neutralization observed [16].
Increasing the IgG concentration further resulted in a return to similar amounts
of attachment as found with infectious virus. This agrees with earlier work using
a single saturating IgG concentration where attachment to various cultured cells
of chicken, mouse and human origin was unaffected [1, 19, 20]. Attachment of
virus neutralized by monomeric IgA was also unimpeded [19]. In contrast to BHK
and tracheal epithelial cells, attachment of IgG-neutralized virus to chicken
erythrocytes was reduced by a greater degree and attachment remained uniformly
low even at the highest IgG concentrations. Thus the target cell can be important
when investigating the neutralization and differences between tracheal epithelial
cells and erythrocytes demonstrate that the latter is a poor model of the in vivo
situation. However, IgG-neutralized virus failed to attach to a B cell lymphoma
cell line [21] emphasizing how each situation has to be assessed individually.
What lies behind these observations? Influenza virus attaches to sialic acid
moieties. On erythrocytes the most abundant sialylated protein is glycophorin A
which extends only a short distance, about 5 nm, from the cell surface [22,23].
It may be that IgG molecules (about 14 nm) are sufficient sterically to hinder
attachment of the virus to the erythrocyte cell but not to a putatively longer
receptor (> 14 nm) on tracheal epithelial or BHK cells. Reduction in attachment
is not due to aggregation of virus because electron microscopy shows that virus
aggregates are able to attach to the cells. Reduction in attachment may be related
to the density of neutralizing antibodies on the virus surface: thus at sub-
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Fig. 4. Neutralization by HC2 of influenza A FPV/R and attachment of virus to mouse
tracheal epithelial cells (-*-). Also shown is the neutralization profile (---). For other
details see legend to Fig. 3. From reference 16.
saturating concentrations IgG molecules are loosely packed on the virus surface
and have freedom to rotate [24-26] which prevents attachment of neutralized
virus to cells. Increasing the IgG concentration results in a closer packing of IgG
molecules on the virus surface and reduces IgG mobility. In turn this facilitates
the attachment of the virus to cell receptors which reach between the IgG
molecules.
What then is the significance to neutralization of aggregation and inhibition of
attachment that occurs at lower IgG to virus ratios? At least for the monoclonal
IgG HC61 the loss of infectivity due to the combined effects of aggregation and
inhibition of attachment match very closely the amount of neutralization
observed (Fig. 5). However for other mabs aggregation preceded neutralization
suggesting that it was either an artifact of electron microscopy or that aggregates
were easily dispersed by normal pipetting procedures, as discussed above.
With antibody of the IgM class, attachment of influenza virus to the three cell
types tested (BHK, tracheal epithelial and chicken erythrocytes) was reduced and
there was no return of attachment as the IgM concentration was increased [15].
The large size of the IgM molecules probably sterically hinders the attachment to
all the cell types although some virus can still attach even at the highest IgM
concentrations used. Neutralization of influenza virus by a murine monoclonal
IgA gave similar results. This antibody is polymeric but unlike human IgA which
usually polymerizes as dimers the mouse IgA is a mixture of dimers, trimers and
tetramers. The monoclonal IgA lacks the secretory component which is only
acquired by the antibody during its passage into external secretions but there is
good agreement with data using polyclonal rat IgA from bile which has a secretory
component [19].
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Fig. 5. Comparison of the actual neutralization of influenza A (FPV/R) by HC61 (---)
with that calculated from the combined effects of aggregation and inhibition of virus
attachment to BHK cells (-A-). For other details see legend to Fig. 3. From reference
16.
Is internalization of virus prevented by neutralizing antibody?
Irrespective of the immunoglobulin isotype, some neutralized virus attached to
cells. It is therefore important to determine whether or not such virus was being
internalized. Pretreatment of cells with bacterial neuraminidase prevented
attachment of infectious, IgG-, IgA- and IgM-neutralized virus indicating that all
used sialic acid moieties as their receptors [15, 16]. Internalization of virus can be
determined by incubating with neuraminidase after attachment has taken place:
virus on the cell surface is detached while internalized virus is not. Therefore an
increase in resistance to neuraminidase action with respect to time would indicate
that internalization was occurring. Between 5 min and 60 min post-inoculation,
resistance of non-neutralized virus to release by neuraminidase increased on both
BHK and tracheal epithelial cells. A similar increase in resistance was found with
IgG-neutralization irrespective of the concentration of antibody used, indicating
that such virus was internalized. In contrast the majority of IgM- and IgA-
neutralized virus was not internalized. However the data are not sufficiently
precise to preclude the possibility that some internalization does take place.
Thus neutralization of influenza virus by the polymeric antibodies, IgM and
IgA, appears to be due in part to inhibition of attachment to cells and in part to
prevention of internalization of the virus that does manage to attach (Table 1).
Virus is aggregated at certain ratios of immunoglobulin to virus but it is not clear
that these aggregates are stable enough to contribute to neutralization.
IgG neutralization is more complex. With high IgG concentrations neutralized
virus is not aggregated and attachment to BHK or tracheal epithelial cells was not
inhibited at all (except on B-lymphoma cells [21]). This IgG-neutralized virus is
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Table 1. Summary of some effects of neutralizing antibodies on influenza virus
type A
IgG IgM IgA*
fA ,A A,KA
[Low] [High] [Low] or [High] [Low] or [High]
Aggregation Yes No Yes No Yes No
Inhibition of Yes No Yes Yes
attachment 50-60% 70-80% 70-90%
Inhibition of No No Yes Yes
internalization
* Polymeric.
internalized by cells. The infectivity of the virus was neutralized by more than
99%, therefore under these conditions IgG-neutralization must involve a later,
intracellular stage of infection. Neutralization at lower IgG concentrations is more
complex: there is some inhibition of attachment but attached virus enters cells
and is probably neutralized by the same mechanism as found with high IgG
concentrations. It is not clear if virus-IgG aggregates are sufficiently stable to
contribute significantly to the loss of infectivity.
'Intracellular' neutralization by IgG
Work on the intracellular mechanism of neutralization has shown that IgG-
neutralized virus is uncoated, losing its lipid envelope in the cytoplasm [27]. This
primary uncoating suggests that fusion of viral and endosomal membranes is
occurring normally but this has yet to be verified directly. Virion RNA and
associated proteins then migrate to the cell nucleus with kinetics indistinguishable
from those of infectious virus but no primary transcription of the virus genome
can be detected [27,28]. The RNA of neutralized virus has been recovered from
cell extracts and shown to be resistant to degradation by RNase whereas that
from infectious virus was sensitive [28]. This suggests that IgG-neutralization
blocks a secondary uncoating step which has to take place before the sub-viral core
can transcribe the viral genome. The failure to initiate transcription is considered
to be an epiphenomenon and we predict that if secondary uncoating could be
achieved artificially, the transcriptase complex would be functional.
We suggest that the binding of neutralizing IgG to the HA spike induces or
prevents a transmembrane signal which is needed to permit secondary uncoating
of the virion core structure. It would seem likely that the major outer core protein,
Ml, which is adjacent to the COOH-terminal tail of the HA would be the protein
most likely to be affected, although M2 may also be involved. We know that such
cores artificially isolated from virus do not transcribe unless uncoated with
detergent [28] and hence have the properties expected of cores from neutralized
virus which are found in the nucleus.
How many molecules of IgG are needed to neutralize a virus particle?
To understand neutralization it is necessary to know if loss of infectivity is a
single-hit process, resulting from the binding of one antibody molecule per virus
particular or is multi-hit. Interpretation of earlier work [29, 30] is uncertain due
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to the polyclonal nature of the antibody used. This has not been resolved by using
monoclonal antibody.
Stoichiometric analysis
If every antibody molecule is neutralizing and every time one molecule binds to
a virus particle it effects neutralization then Poissonian distribution states that
when a virus population is neutralized by 63% there will be, on average, one
antibody molecule per virus particle. However, experimentally it is found that
there are 70 IgG molecules bound per influenza virus particle [8]. This was
confirmed by electron microscopy showing, by colloidal gold labelling, the
presence of IgG bound to virus at a dilution 100-fold less than that required to
initiate neutralization. Further evidence, that at the commencement of neutral-
ization there is not one but several molecules of monoclonal IgG bound per virus
particle, comes from the enhancement of infectivity when such virus mixed with
sub-neutralizing amounts of antibody are titrated on cells bearing Fc receptors
[31,32].
Kinetic analysis
Kinetics of neutralization (reviewed in 7) can be represented by equation (1):
kinf +ab (Vn'eutab), (1)
where Vinf = infectious virus, Vneut = neutralized virus. This is a second-order
reaction but it displays pseudo-first-order kinetics because neutralization is highly
dependent on the concentration of antibody (ab) and less on virus concentration.
The rate constant (k) can be calculated by plotting log1o Vt/VO against time (t)
according to equation (2):
log10 (2.D) (2)
where Vt and V0 are the infectivity titres at time t and 0 andD is the dilution factor
or concentration of antibody. Fig. 6 shows a plot for the neutralization of influenza
A virus by monoclonal IgG and the derived rate constant, k.
The number of antibody molecules required for neutralization to occur can be
calculated from equation (3):
log1o V = 1-(1-ekt/D )n, (3)
where n is the number of antibody 'hits' required for neutralization; other
symbols are as above. If n = 1 (i.e. single hit) then a plot of log Vt/VO with respect
to time gives a straight line and infectivity falls immediately. If n is greater than
1 (i.e. multi-hit) then a curve results and there is an initial lag period where little
or no loss of infectivity occurs. For influenza A virus the kinetic data clearly show
a single-hit mechanism (Fig. 6). The single-hit nature of the mechanism was
further confirmed by varying the IgG concentration and comparing the predicted
and actual amounts of neutralization (Fig. 7). These data confirm the conclusions
of earlier work despite its use of heterogeneous polyclonal antibody [29].
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Fig. 6. Comparison of the observed rate of neutralization of influenza A (FPV/R) by
HC2 (12 ,ug/ml; 77 uM) (e) with that calculated when 1, 5 or 10 'hits' are required for
neutralization ( ): see text for details. The rate constant (K) was calculated as
described in the text.
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Fig. 7. Comparison of the actual ( ) and predicted (** ) rates of neutralization of
influenza A (FPV/R) by HC2 when different concentrations of IgG are used.
From the limited data so far available it seems that neutralization kinetics of
IgM and IgG differ fundamentally. When influenza virus is incubated with IgM
there is a significant lag of about 4 min before neutralization occurs suggesting
that it follows multi-hit kinetics (M. C. Outlaw and N. J. Dimmock, unpublished
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data). This is consistent with biochemical data showing that IgM neutralizes by
inhibition of virus attachment to cells and the internalization of virus that does
attach (see above) and with EM data showing that IgM binds to virus at a dilution
approximately 100-fold greater than that necessary to elict neutralization [33].
CRITICAL SITE MODEL OF IgG-NEUTRALIZATION
Data outlined above show that IgG-neutralization is a single-hit process and
yet, at a dilution of antibody which causes 63% neutralization, there are on
average 70 molecules of IgG bound per virus particle [8]. These apparently
contradictory data can be resolved by invoking a critical site model which states
that there are relevant (or critical) and irrelevant sites on the virus particle.
Antigenically these sites are identical but differ functionally in that the binding of
antibody to a relevant site leads to neutralization whereas binding to an irrelevant
site does not. We propose that HA spikes differ only in the contact they make with
the virus core: it is only through the contact between relevant spikes and the core
that the neutralization signal preventing secondary uncoating is made. If one
assumes that the ratio of relevant to irrelevant spikes is 1 to 70, then the binding
of one IgG is capable of causing neutralization by binding to a relevant spike (i.e.
single hit kinetics) but on average 70 IgG molecules have to bind before a relevant
spike is hit. Interestingly a very similar mechanism of neutralization has been
proposed for poliovirus where again the kinetics and stoichiometric data appear at
odds [17]. There are four IgG molecules bound per poliovirus particle at 63%
neutralization. An alternative stepwise model of neutralization was also suggested
[17], where the binding of each IgG reduced the infectivity of each individual
poliovirus particle by a factor of 3/4. Unfortunately the data were not sufficiently
precise to distinguish between this and the critical site model.
MORE THAN ONE MECHANISM OF IgG-NEUTRALIZATION MAY BE OPERATING
AT THE SAME TIME
We have argued that IgG can neutralize influenza virus by binding to the
haemagglutinin spike inducing an irreversible conformational change in the
subviral core which prevents secondary uncoating of the virus. If this is the case,
what role do aggregation of virus and inhibition of virus attachment, which occur
at lower IgG concentrations, play in neutralization?
When low IgG concentrations were used then good agreement was found (with
the monoclonal antibody HC61 (Fig. 5), but less so with other neutralizing IgG2a
monoclones) between the potential loss of infectivity due to the combined effects
of aggregation and inhibition of attachment, and the actual loss of infectivity
found. This could be taken as implying a causal relationship between these
phenomena and neutralization.
If the binding of a single IgG molecule to the virus resulted in neutralization,
then it could be argued that only virus already neutralized was aggregated and
failed to attach. The quantitative data discussed above show that this is not the
case. On average many IgG molecules bind to the virus particle before
neutralization occurs but the binding of one IgG was capable of causing
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Fig. 8. Comparison of the amount of neutralization of FPV/R by a monoclonal IgG2a
(HC10) with the number of 1251-labelled IgG molecules bound per virus particle. From
reference 8.
neutralization. The neutralization-relevant spike hypothesis resolves this dilemma
but it is unlikely that either aggregation or inhibition of virus attachment are
dependent on whether IgG binds to neutralization-relevant spikes or not. The
proportion of relevant to irrelevant spikes will be constant within a given virus
preparation and therefore the probability of an IgG molecule binding to a relevant
spike will also be constant. If the critical site model of influenza virus
neutralization only was operating then a straight line should result when
neutralization is plotted against the number of IgG molecules bound. Fig. 8 shows
that this is not the case. At low IgG concentration, when few IgG molecules
(< 200 per virion) are bound, neutralization was more efficient than when higher
IgG concentrations were used and more IgG molecules (> 200 per virion) are
bound. The difference in neutralization efficiency can be explained by introducing
mechanisms of neutralization other than the neutralization-relevant spike
hypothesis into the process. The initial efficient phase of neutralization shown in
Fig. 8 coincides with the conditions in which both aggregation and inhibition of
virus attachment to cells occur. It is likely that aggregation and inhibition of
attachment either separately or in combination are responsible for the increased
neutralization efficiency at low IgG concentration.
DISCUSSION
We believe that what we have learned about the neutralization of influenza A
viruses is relevant to all other types of viruses and this leads us to suggest that
there are as many mechanisms of neutralization as there are events in the initial
stages of infection. However for any permutation of components in the
neutralization reaction one particular mechanism would appear to operate, and
this is decided by the unique characteristics of the particle itself, the epitope
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specificity and isotype of the immunoglobulin, the ratio of immunoglobulin
molecules to virus particles and finally the cell itself and its receptors.
The virus occupies a central position. The diversity of virus structures and
infectious routes means that the findings pertaining to one type of virus cannot be
automatically interpreted as applying to others. It is perhaps not surprising that
there is no single mechanism of neutralization operating for all viruses.
The neutralizing antibody molecule is important, both in terms of its epitope
specificity and isotype. Even before contact with a cell, virus can be aggregated
by antibody with the result that the number of infectious units is reduced. The
valency, affinity, ratio of antibody to virus and concentration of reactants will
decide on the efficiency of aggregation. There is evidence that aggregation is a
mechanism whereby poliovirus is neutralized by IgG [34,35] but this is entirely
distinct from neutralization which results from conformational changes in the
virion coat proteins [36]. However with influenza virus there is aggregation only
in a narrow range of antibody (IgG, IgA orIgM) to virus ratio and at best it would
seem to play only a minor role in neutralization.
Irrespective of isotype, if an antibody binds directly to the attachment site on
a viral coat protein it can prevent attachment. If antibody binds nearby the
inhibition of attachment will depend upon its molecular dimensions and other
properties such as rotational radius. The larger polymeric immunoglobulins IgM
and IgA might be intuitively expected to be more efficient 'blockers' than IgG;
this appears to be the case with influenza virus but there are few other data to
draw on.
With respect to IgG, there is now a considerable body of published work to show
that only in a minority of instances of IgG-neutralization (e.g. reovirus, rotavirus,
rhinovirus and foot-and-mouth disease virus [37-40]) does inhibition of virus
attachment fully account for the loss of infectivity observed under the particular
conditions studied. Attachment of other viruses may be reduced by the binding of
antibody but the magnitude of the reduction in attachment makes only a
contribution to the neutralization found. A very clear illustration of the fact that
IgG does not necessarily affect attachment is provided by those neutralization
escape mutants which still bind their selecting monoclonal antibody [35,41].
Secondly viruses have many attachment sites for cells (3000 in influenza virus, 60
in poliovirus) and since the majority of infectivity is neutralized when there are 70
(influenza virus; [8]) or 4 (poliovirus; [17]) molecules of IgG per particle, it seems
unlikely that binding of low amounts of antibody would affect attachment.
The concept of neutralization sites is fundamental to the understanding of
neutralization. To neutralize influenza virus IgG must bind to one of 4 or 5
antigenic sites on the HA [18]; those that bind to epitopes outside these sites do
not neutralize the virus [42-44]. Such non-neutralizing antibodies may be active
in vivo against virus or virus-infected cells by fixing complement enhancing
phagocytosis or mediating lysis of infected cells by antibody-dependent cell
cytotoxicity (ADCC); these mechanisms may well be important in protection and
recovery from virus infections but are beyond the scope of this article.
Our data with influenza virus underline the importance of the antibody to virus
ratio in relation to neutralization. Antibody-virus-cell interactions are affected
in profoundly different ways depending on whether or not the conditions are
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saturating, sub-saturating or sub-neutralizing. Many studies have used a single
concentration of antibody, so that comparisons with other studies which used
different antibody concentrations have been confusing.
If neutralized virus attaches to a cell and is internalized normally then
neutralization must occur intracellularly. Some enveloped viruses such as
influenza enter cells by adsorptive endocytosis and then the viral envelope and
endosomal membranes fuse to release subviral cores into the cell proper [11,12].
This fusion is mediated by surface proteins which undergo a conformational
alteration induced by the acidification of the endosome compartment [45]. It is
therefore conceivable that the bound antibody prevents the conformational
alteration and hence fusion, and thereby traps the virus in the endosome. This
fuses with primary lysosomes and the virus particle is degraded. Such a
mechanism has been described for West Nile virus [46]. Other viruses, including
paramyxoviruses and HIV [13] fuse at neutral pH with the plasma membrane
but the principle of antibody interfering with fusion remains the same. Evidence
with influenza virus is conflicting: although some workers have suggested that
neutralizing antibodies prevent conformational change in the HA and block low
pH-induced fusion of the virus with both liposomes and erythrocytes [47,48],
others [49] have shown that bound antibody does not affect the acid-induced
change in the HA; the issue remains unresolved. It may also be important that the
binding of virus to liposomes used to demonstrate fusion in these studies was not
mediated by the natural receptor molecule (sialic acid) but through electrostatic
attraction and therefore may be giving misleading results.
Further we have suggested above that the erythrocyte which is often used to
study fusion events has short receptor molecules which are not typical of the
majority of cell types and would not therefore appear to be the most appropriate
cell for the study of neutralization. The way in which a cell type reacts with
neutralized virus has received little attention. The erythrocyte is one example but
other cells which show quantitative or qualitative differences in neutralization flag
this as a factor meriting closer attention [50-52]. For example, one monoclonal
IgG neutralized La Crosse virus on BHK cells but not on a mosquito cell line while
a second monoclonal IgG to the same protein neutralized on mosquito but not
BHK cells [53]. It seems likely that properties of the cell receptor unit used by the
virus to attach to the cell membranes are crucial here. Such molecules, now being
identified, are normal components of the cell surface. Not surprisingly they are a
diverse collection of molecules, playing various roles in homeostatic and immune
recognition processes [9].
Data outlined above suggest that IgG neutralization of influenza virus occurs at
a stage following endosomal fusion. This would imply that a signal, presumably
conformational, is transmitted from the surface protein to which the antibody
binds to the subviral core. Such an event is a common means of communication
across membranes for homeostatic mechanisms, intercellular communication and
antigen recognition whereby ligands bind to receptors on the outside of the cell
and trigger intracellular processes. Antibodies can mimic the effect of some
ligands, for example in stimulating lymphocyte activation or hormone receptors.
An analogous situation may occur with enveloped viruses although none has been
conclusively demonstrated to date. However, antibodies are known to induce
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conformational changes in virion proteins [54, 55]. We believe that IgG-
neutralization of influenza virus blocks a late stage of infection and prevents
uncoating of the subviral particle (secondary uncoating) [28] but with other
systems it is possible that viral enzymes within the virus particle are inhibited.
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